Literature DB >> 10664225

Perinatal indomethacin treatment and neonatal complications in preterm infants.

R Ojala1, S Ikonen, O Tammela.   

Abstract

UNLABELLED: To evaluate the incidence of neonatal complications among infants exposed to indomethacin antenatally, postnatally or both ante-and postnatally (combined), the records of 240 infants of gestational ages between 23 to 32 weeks were analysed retrospectively. Antenatal indomethacin treatment for longer than 2 days with a daily or cumulative dosage >/=150 mg correlated with a significantly higher incidence of grade I-II intraventricular haemorrhage. Combined exposure, cumulative antenatal exposure >/=150 mg and duration of antenatal exposure of more than 2 days was associated with necrotising enterocolitis and a cumulative exposure with sepsis. There was no independent association between indomethacin exposure and pneumothorax, bronchopulmonary dysplasia or respiratory distress syndrome.
CONCLUSION: Preterm infants with exposure to antenatal indomethacin might be at increased risk of grade I and II intraventricular haemorrhage and those with both ante- and postnatal exposure at an increased risk of necrotising enterocolitis and sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10664225     DOI: 10.1007/s004310050040

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.

Authors:  Sanjiv B Amin; Robert A Sinkin; J Christopher Glantz
Journal:  Am J Obstet Gynecol       Date:  2007-11       Impact factor: 8.661

2.  Renal follow up of premature infants with and without perinatal indomethacin exposure.

Authors:  R Ojala; M Ala-Houhala; S Ahonen; A Harmoinen; V Turjanmaa; S Ikonen; O Tammela
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

Review 3.  Pharmacological treatment of migraine during pregnancy and breastfeeding.

Authors:  Siri Amundsen; Hedvig Nordeng; Kateřina Nezvalová-Henriksen; Lars Jacob Stovner; Olav Spigset
Journal:  Nat Rev Neurol       Date:  2015-04       Impact factor: 42.937

4.  Reversible ductus arteriosus constriction due to maternal indomethacin after fetal intervention for hypoplastic left heart syndrome with intact/restrictive atrial septum.

Authors:  Melanie Vogel; Louise E Wilkins-Haug; Doff B McElhinney; Audrey C Marshall; Carol B Benson; Virginia Silva; Wayne Tworetzky
Journal:  Fetal Diagn Ther       Date:  2009-12-17       Impact factor: 2.587

Review 5.  Nonsteroidal anti-inflammatory agents in neonates.

Authors:  John L Morris; David A Rosen; Kathleen R Rosen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Tubular proteinuria in pre-term and full-term infants.

Authors:  Riitta Ojala; Marja Ala-Houhala; Aimo P T Harmoinen; Tiina Luukkaala; Jukka Uotila; Outi Tammela
Journal:  Pediatr Nephrol       Date:  2005-11-17       Impact factor: 3.714

7.  Association of Prenatal Ibuprofen Exposure with Birth Weight and Gestational Age: A Population-Based Sibling Study.

Authors:  Kateřina Nezvalová-Henriksen; Mollie Wood; Olav Spigset; Hedvig Nordeng
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.